Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Anika Bilal MD

Anika Bilal MD

Post-Doctoral Research Scientist, AdventHealth Translational Research Institute, Orlando, Florida

Anika Bilal, MD, is a postdoctoral research scientist at AdventHealth Research Institute (AHRI) in Orlando, Florida. She earned her medical degree (MD) from Lahore, Pakistan. After practicing internal medicine for 11 years in Pakistan, Dr. Bilal joined the diabetes team at AdventHealth Translational Research Institute, Orlando, Florida. Her research focuses on hypoglycemia and impaired awareness of hypoglycemia in type 1 diabetes with special interest in role of latest diabetes technology in preventing diabetic complications. Another area of her research interest includes the role of adjunctive diabetes medications in people with type 1 diabetes and the effects of newer antihyperglycemic drugs in older adults with type 2 diabetes.

Disclosures

Dr. Bilal has no relevant disclosures.

Recent Contributions to PracticeUpdate:

  1. Effectiveness and Safety of Automated Insulin Delivery Compared With Other Modalities of Type 1 Diabetes Treatment During Ramadan Intermittent Fasting

Most Read This Week

Recently Updated